By Fineline Cube 
Wuxi Apptec Co., Ltd. (SHA: 603259, HKG: 2359) today announced third‑quarter 2025 financial results, delivering operating revenue of RMB 12.06 billion (up 15.3 % YoY) and net profit attributable to the parent company of RMB 4.22 billion (up 42.0 % YoY). For the first nine months, the company generated RMB 32.86 billion in revenue (18.6 % YoY) and RMB 12.08 billion in net profit (84.8 % YoY).
Highlights
| Metric | Q3 2025 | YoY % | Q1‑Q3 2025 | YoY % |
|---|---|---|---|---|
| Operating revenue | RMB 12.06 bn | +15.3 % | RMB 32.86 bn | +18.6 % |
| Net profit (parent) | RMB 4.22 bn | +42.0 % | RMB 12.08 bn | +84.8 % |
Segment Performance
- WuXi Chemistry – RMB 25.98 bn, +29.3 % YoY
- WuXi Testing – RMB 4.17 bn, flat YoY
- WuXi Biology – RMB 1.95 bn, +6.6 % YoY
Geographic Breakdown
| Region | Revenue | YoY % |
|---|---|---|
| United States | RMB 22.15 bn | +31.9 % |
| Europe | RMB 3.84 bn | +13.5 % |
| China | RMB 5.04 bn | +0.5 % |
| Japan, South Korea & Others | RMB 1.42 bn | +9.2 % |
Outlook
Wuxi Apptec projects double‑digit revenue growth for continuing operations in 2025, raising the growth range from 17‑18 % (previously 13‑17 %). The company has adjusted its full‑year revenue guidance upward to RMB 43.5‑44.0 billion from the prior RMB 42.5‑43.5 billion band.
Forward‑Looking Statements
This release contains forward‑looking statements that involve risks and uncertainties. Actual results may differ materially.-Fineline Info & Tech